Review Article
Volume 3 Issue 7 - 2020
Novel Coronavirus 2019 (COVID-19) Out-break: A Review
Showkat Ahmad Bhat1, Sabhiya Majid2, Azher Arafah3 and Muneeb U Rehman2,3*
1Department of Biochemistry, Government Medical College Doda, Jammu and Kashmir, India
2Department of Biochemistry, Government Medical College Srinagar, Srinagar, Jammu and Kashmir, India
3Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
*Corresponding Author: Muneeb U Rehman, Department of Biochemistry, Government Medical College Srinagar, Srinagar, Jammu and Kashmir, India and Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Received: April 25, 2020; Published: June 18, 2020




Abstract

There is a new public health crisis threatening the world with the emergence and spread of 2019 novel coronavirus (2019-nCoV). COVID-19 epidemic of coronavirus disease originating in Wuhan, China become a key public health challenge for the whole world and World Health Organization announced this epidemic as public health emergency of international concern. Novel coronavirus (2019-nCoV) is a new strain that was discovered in 2019 and has not been previously identified in humans and has not been previously identified in humans. The virus originated in bats and was transmitted to humans through yet unknown intermediary animals in Wuhan, Hubei province in China during the month of December 2019. Till date 96,000 reported cases and 3300 reported deaths because of COVID-2019. The disease is transmitted by inhalation or contact with infected droplets with incubation period of 2 to 14 days. The symptoms are usually fever, sore throat, dry cough, breathlessness, fatigue while many people are asymptomatic. Coronavirus (2019-nCoV) may progress to pneumonia, acute respiratory distress syndrome (ARDS) and can cause multi-organ dysfunction. Currently diagnosis is done by demonstration of the virus in respiratory secretions by special molecular tests like real-time reverse-transcription-polymerase-chain-reaction (RT-PCR), Radiological examinations (chest CT). It is paramount to implement infection control practices by infection source controlling, transmission route blocking, and susceptible population protection. Early preventive measures can be home isolation of suspected cases and those with mild illnesses and strict infection control measures at hospitals that include contact and droplet precautions. In conclusion time alone will tell how the virus will impact lives in world and in India. Future outbreaks of such viruses and pathogens of zoonotic origin are likely to continue, so apart from curbing this outbreak, efforts should be made to devise comprehensive measures to prevent future outbreaks of zoonotic origin. From Research studies and review papers it was concluded that Base line testing for symptomatic patient should be started with leukocyte counts, C-reactive protein, Erythrocyte sedimentation rate and D-dimer were also observed at high.

Keywords: Coronavirus Disease (COVID-19); Novel Coronavirus (2019-nCoV); Sources, Transmission Route; Pathogenicity; Symptoms

References

  1. Wang C., et al. “A novel coronavirus outbreak of global health concern”. Lancet10223 (2020): 470-473.
  2. Liu Z., et al. “Understanding Unreported Cases in the 2019-Ncov Epidemic Outbreak in Wuhan, China, and the Importance of Major Public Health Interventions”. Biology3 (2020): 50.
  3. Woo PC., et al. “Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia”. Journal of Virology2 (2005): 884-895.
  4. Chan JF., et al. “Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan”. Emerging Microbes and Infections 1 (2020): 221-236.
  5. Chan JF., et al. “A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster”. Lancet10223 (2020): 514-523.
  6. Roujian Lu., et al. “Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding”. Lancet 10224 (2020): 565-574.
  7. Centers for Disease Control and Prevention. “Disease burden of influenza” (2020).
  8. Li Q., et al. “Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia”. New England Journal of Medicine 382 (2020): 1199-1207.
  9. Phelan AL., et al. “The novel coronavirus originating in Wuhan, China: challenges for global health governance”. Journal of the American Medical Association (2020).
  10. Mahase E. “China coronavirus: WHO declares international emergency as death toll exceeds 200”. British Medical Journal 368 (2020): m408.
  11. World Health Organization. “Coronavirus disease 2019 (COVID-19): situation report-36” (2020).
  12. Gralinski LE and Menachery VD. “Return of the Coronavirus: 2019-nCoV”. Viruses2 (2020): 135.
  13. Hui DS., et al. “The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan, China”. International Journal of Infectious Diseases 91 (2020): 264-266.
  14. World Health Organization. “Novel Coronavirus-Japan (ex-China)” (2020).
  15. Zhou P., et al. “Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin”. bioRxiv (2020).
  16. Chen N., et al. “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study”. The Lancet10223 (2020): 507-513.
  17. W Wang., et al. “Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China”. Journal of Medical Virology 4 (2020): 441-447.
  18. C Huang., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet 10223 (2020): 497-506.
  19. J Lei., et al. “CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia”. Radiology 1 (2020): 18.
  20. World Health Organization. “Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care”. Geneva: World Health Organization (2014).
  21. Ong SW., et al. “Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient”. Journal of the American Medical Association 16 (2020): 1610-1612.
  22. Burke RM., et al. “Active monitoring of persons exposed to patients with confirmed COVID-19 - United States, January-February 2020”. Morbidity and Mortality Weekly Report 9 (2020): 245-246.
  23. World Health Organization. “Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) 16-24 February 2020”. Geneva: World Health Organization (2020).
  24. Wang M., et al. “Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro”. Cell Research3 (2020): 269-271.
  25. Phan T. “Novel coronavirus: From discovery to clinical diagnostics”. Infection, Genetics and Evolution 79 (2020): 104211.
  26. Rahman A and Sarkar A. “Risk Factors for Fatal Middle East Respiratory Syndrome Coronavirus Infections in Saudi Arabia: Analysis of the WHO Line List, 2013-2018”. American Journal of Public Health9 (2019): 1288-1293.
  27. Zhu N., et al. “A novel coronavirus from patients with pneumonia in China, 2019”. New England Journal of Medicine8 (2020): 727-733.
  28. Holshue ML., et al. “First case of 2019 novel coronavirus in the United States”. New England Journal of Medicine10 (2020): 929-936.
  29. Chung M., et al. “CT imaging features of 2019 novel coronavirus (2019-nCoV)”. Radiology (2020): 200230.
  30. Kanne JP. “Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist”. Radiology1 (2020): 16-17.
  31. Jin YH., et al. “A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus [2019-nCoV] infected pneumonia [standard version]”. Military Medical Research 1 (2020): 4.
  32. Teppei Imai., et al. “SARS Risk Perceptions in Healthcare Workers, Japan”. Emerging Infectious Diseases3 (2005): 404-410.
  33. Tanu Singhal. “A Review of Coronavirus Disease-2019 (COVID-19)”. The Indian Journal of Pediatrics4 (2020): 281-286.
  34. Chang D., et al. “Protecting health-care workers from subclinical coronavirus infection”. Lancet Respiratory Medicine 3 (2020): e13.
  35. Li J., et al. “Game consumption and the 2019 novel coronavirus”. Lancet Infectious Diseases 3 (2020): 275-276.
Citation: Muneeb U Rehman., et al. “Novel Coronavirus 2019 (COVID-19) Out-break: A Review”. EC Clinical and Medical Case Reports 3.7 (2020): 26-34.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 26, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk